Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine prilocaine cutaneous spray for primary premature ejaculation
CTR20260491Phase 3Active
- Sponsor
- Huiren Pharmaceutical
- Start
- May 2026
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine + prilocaine in premature ejaculation (PE), sponsored by Huiren Pharmaceutical. Started May 2026; status: active.
02
Drugs
lidocaine + prilocaine
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on CTR20260491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260491.